Bookcover of Vaccine therapy of colorectal cancer patients with tumor antigens
Booktitle:

Vaccine therapy of colorectal cancer patients with tumor antigens

Cancer vaccines

LAP LAMBERT Academic Publishing (2010-11-15 )

Books loader

Omni badge eligible for voucher
ISBN-13:

978-3-8433-5618-3

ISBN-10:
3843356181
EAN:
9783843356183
Book language:
English
Blurb/Shorttext:
For the first time two tumor-associated antigens were evaluated as adjuvant therapy in combination with granulocyte colony stimulating factor (GM-CSF) for patients with colorectal cancer. The first study involved immunization with the protein, carcinoembryonic antigen (CEA) during one year. This vaccination regimen induced a strong immunoglobulin 1 (IgG1) and IgG4 and a moderate IgG2 response against CEA. The humoral as well as the T cell responses were protracted up to 36 months. The dose of CEA had no or modest effect on these responses. The anti-CEA IgG titers related significantly to survival. Functional HLA-DR epitopes of CEA could be defined which may serve as components of a vaccination strategy. The other vaccine strategy consisted of the epithelial cell adhesion molecule (Ep-Cam) expressed as a transgene in a viral vector, ALVAC. Patients were immunized over 6 weeks. No anti-Ep-Cam specific humoral response was induced, but eventually Ep-Cam specific type 1 T cells were induced. Both vaccines were well tolerated. GM-CSF augmented the responses. A low incidence of GM-CSF antibodies that did not neutralize the effect of GM-CSF was observed.
Publishing house:
LAP LAMBERT Academic Publishing
Website:
https://www.lap-publishing.com/
By (author) :
Gustav Ullenhag
Number of pages:
144
Published on:
2010-11-15
Stock:
Available
Category:
Clinical disciplines
Price:
59.00 €
Keywords:
colorectal cancer, GM-CSF, vaccination, CEA, ALVAC-KSA, IgG subclass, épitopes

Books loader

Newsletter

Adyen::amex Adyen::mc Adyen::visa Adyen::cup Adyen::unionpay Paypal Wire Transfer

  0 products in the shopping cart
Edit cart
Loading frontend
LOADING